Epalex Corporation
Get Full AccessDescription
- EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a seizure warning sign (aura) occurs, the patient will be able to prevent the development of a full-blown seizure through the use of a pocket nebulizer to deliver a powerful antiseizure medication that rapidly enters the brain and stops the seizure. The effect of the drug dissipates within minutes, allowing the patient to resume normal daily activity. The inhaler is also used to stop migraine attacks that are refractory to currently available migraine treatments.
-
Headquarters:305 Lytton Avenue , Palo Alto, California, United States
More -
Phone Number: +1 215-882-4674
-
Website: https://www.epalex.com
-
Employees:5
-
Revenue:$1 - 10M
-
Legal Name:Epalex Corporation
-
Epalex Corporation's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Epalex Corporation
-
Where are Epalex Corporation's Headquarters?
Epalex Corporation's Headquarters are in 305 Lytton Avenue ,Palo Alto,California,United States
-
What is Epalex Corporation's phone number?
Epalex Corporation's phone number is +1 215-882-4674
-
What is Epalex Corporation's official website?
Epalex Corporation's official website is https://www.epalex.com
-
What is Epalex Corporation's Revenue?
Epalex Corporation's revenue is $1 - 10M
-
What is Epalex Corporation's NAICS code?
Epalex Corporation's NAICS code is 325412
-
How many employees are working in Epalex Corporation
Epalex Corporation has 5 employees
-
What is Epalex Corporation's Industry?
Epalex Corporation is in the industry of Pharmaceuticals
-
Who is Epalex Corporation's CEO?
Epalex Corporation's CEO is Brendan Magrab

